The quinazoline skeleton is an important pharmacophore that occurs frequently in medicinal chemistry literature. Quinazolines are an important class of compounds found in many naturally occuring products, and are employed as potent cytotoxic agents. Substituted quinazolines have fungicidal, anti-microbial, CNS stimulant, diuretic, anti-inflammatory anticancer, anti-hypertensive, 1 anti-analgesic, antihelminitic, antitumour and anti-HIV properties. 2 A structure analysis provides an oppurtunity to study biological activity and its implication in the structural requirement needed for binding the receptors. In view of the above, the title compound was synthesized and its crystal structure is reported here.
a period of 400 s. Successive frames were scanned in steps of 5p er minute with an oscillation range of 5˚. Image processing and data reduction were done using Denzo. 3 The reflections were merged with Scalepack. All of the frames could be indexed using a primitive triclinic lattice. Absorption correction was not applied. The structure was solved by direct methods using SHELXS-97. All of the non-hydrogen atoms were revealed in the first Fourier map, itself. A least-squares refinement using SHELXL-97 with isotropic temperature factors for all the non- The title compound, C20H15N3O, was synthesized and the structure was investigated by X-ray crystallography. The compound crystallizes in the triclinic crystal class in the space group P1 with cell parameters a = 7.724 (6) hydrogen atoms converged the residual R1 to 0.1608. Subsequent refinements were carried out with anisotropic thermal parameters for non-hydrogen atoms and isotropic temperature factors for the hydrogen atoms, which were placed at chemically acceptable positions. After eight cycles of refinement the residuals converged to 0.0629. The details of crystal data and refinement are given in Table 1  Table 2 and Table 3 give list of the bond lengths and bond angles, respectively, which are in good agreement with the standard values. An ORTEP of the molecule with thermal ellipsoids drawn at 50% probability is shown in Fig. 2 .
The fused benzimidazole ring is planar with a maximum deviation of 0.004(2)˚A for atom C9. The geometrical paramaters of the imidazole ring system are consistent with those reported in literature. 4 In the imidazole ring, there is significant shortening of the N8-C9 bond and lengthening of the N8-C7 bond. This indicates a failure of the delocalized aromatic system, which might be expected for this class of molecules. The bond lengths and angles within the central -N bond distance of 1.426 Å. 5 The quinazoline ring system deviates from planarity with the atom C17 deviating 0.177(2)Å from the least-squares plane defined by atoms N1/C9/C10/C15/N16/C17. The imidazole ring and the dihydropyrimidine ring are nearly coplanar, as indicated by the dihedral angle value of 4.63(13)Å. The dihedral angle value of 87.98(11)˚ between the hydroxyphenyl ring and the dihydropyrimidine ring plane indicates that the latter is nearly orthogonal to the former. A study of the torsion angles, asymmetric parameters and leastsquares plane calculations reveals that the dihydropyrimidine ring is in the skew-boat conformation. This is confirmed by the puckering parameters, 6 Q = 0.2848(3)Å, θ = 59.51(46)˚ and φ = 270.4(5)˚. Literature survey reveals, that in most of the experiments the dihydropyrimidine ring exists in a halfchair/flat boat-type conformation. 7 Further, the substitution at C2-position will play a crucial role in the dihydropyrimidine ring conformation. That is, if the substituent is compact (such as O, S, etc.) the dihydropyrimidine ring acquires a half-chair or boat conformation. On the other hand, if the substituent is bulky, the ring acquires a sofa conformation.
The torsion angle values of -62.9(2)˚ and 57.2(3)˚ for N16-C17-C18-C19 and N1-C17-C18-C19, respectively, determine the inter-ring conformation of the junction between the hydroxyphenyl ring and the dihydrobenzimidazo quinazoline ring systems. This value being closer to 60i ndicates that, the hydroxy phenyl ring bisects the plane of the dihydrobenzimidazo quinazoline ring plane. The molecule possesses a chiral centre at C17. The structure exhibits intermolecular hydrogen bonds of the type N-H·O and O-H·N. The intermolecular hydrogen bonds are between the nitrogen of the dihydropyrimidine ring and the imidazole ring with that of the hydroxy phenyl ring. The intermolecular hydrogen bonds are N16-H16·O24, which has a length of 3.006(4)Å with an angle of 173(2)˚, and O24-H24·N8, which has a length of 2.674(3)˚ and an angle of 172(1)˚ with symmetry codes -1+x, y, z and 1+x, -1+y, z respectively. The stability of the crystal structure can be accounted for by these hydrogen bonds. The packing of the molecules indicates that the molecule are interlinked by the intermolecular hydrogen bonds to form a twodimensional sheet-like arrangement along the ab plane. ANALYTICAL SCIENCES 2008, VOL. 24 Table 2 Bond lengths (Å) Length Atoms Length Atoms Table 3 Bond angles (˚) Angle Atoms Angle Atoms Fig. 2 ORTEP drawing of the molecule with thermal ellipsoids drawn at 50% probability.
